Management of antithrombotics in situations ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
Titre :
Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation
Auteur(s) :
Lemesle, Gilles [Auteur]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Bauters, Christophe [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Bonello, Laurent [Auteur]
Hôpital Nord [CHU - APHM]
Mediterranean Association for Research and Studies in Cardiology [MARS cardio]
Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research [C2VN]
Fauchier, Laurent [Auteur]
Éducation Éthique Santé EA 7505 [EES]
CHU Trousseau [Tours]
Cayla, Guillaume [Auteur]
Hôpital Universitaire Carémeau [Nîmes] [CHU Nîmes]
Marijon, Eloi [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Paris-Centre de Recherche Cardiovasculaire [PARCC (UMR_S 970/ U970)]
Guenoun, Maxime [Auteur]
Hôpital Européen [Fondation Ambroise Paré - Marseille]
Schurtz, Guillaume [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Ninni, Sandro [Auteur]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Richardson, Marjorie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Albert, Franck [Auteur]
Hôpitaux de Chartres [Chartres]
Cohen, Serge [Auteur]
CHU Saint-Antoine [AP-HP]
Lamblin, Nicolas [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Danchin, Nicolas [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]

Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Bauters, Christophe [Auteur]

Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Bonello, Laurent [Auteur]
Hôpital Nord [CHU - APHM]
Mediterranean Association for Research and Studies in Cardiology [MARS cardio]
Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research [C2VN]
Fauchier, Laurent [Auteur]
Éducation Éthique Santé EA 7505 [EES]
CHU Trousseau [Tours]
Cayla, Guillaume [Auteur]
Hôpital Universitaire Carémeau [Nîmes] [CHU Nîmes]
Marijon, Eloi [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Paris-Centre de Recherche Cardiovasculaire [PARCC (UMR_S 970/ U970)]
Guenoun, Maxime [Auteur]
Hôpital Européen [Fondation Ambroise Paré - Marseille]
Schurtz, Guillaume [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Ninni, Sandro [Auteur]

Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Richardson, Marjorie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Albert, Franck [Auteur]
Hôpitaux de Chartres [Chartres]
Cohen, Serge [Auteur]
CHU Saint-Antoine [AP-HP]
Lamblin, Nicolas [Auteur]

Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Danchin, Nicolas [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Titre de la revue :
International Journal of Cardiology
Pagination :
15-21
Éditeur :
Elsevier
Date de publication :
2022-02
ISSN :
0167-5273
Mot(s)-clé(s) en anglais :
Coronary artery disease
Atrial fibrillation
Oral anticoagulation
Antiplatelet therapy
Survey Evidence-based medicine
Atrial fibrillation
Oral anticoagulation
Antiplatelet therapy
Survey Evidence-based medicine
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background: If several randomized studies allowed to better apprehend what should be the best antithrombotic strategy in patients with concomitant coronary artery disease (CAD) and atrial fibrillation (AF), there are still ...
Lire la suite >Background: If several randomized studies allowed to better apprehend what should be the best antithrombotic strategy in patients with concomitant coronary artery disease (CAD) and atrial fibrillation (AF), there are still several clinical situations with a gap of evidence.Methods: We conducted a national French survey in September-October 2020 among cardiologists in order to assess what are daily practices regarding the antithrombotic management in several specific clinical settings where no or little scientific evidence is available. The questionnaires were built by a committee of 6 cardiologists routinely involved in the field of CAD and/or AF.Results: Among the 6388 French cardiologists, 483 (7.6%) cardiologists participated to the survey. The rate of participation was rather homogeneous across the country. The mean age of participants was 48 +/- 12.7. There were 134 women (27.7%) and 349 men. Altogether, 181 (37.5%) cardiologists worked in private, 153 (31.7%) in non-universitary public and 83 (17.2%) in universitary public centers. The remaining had shared activity. Among the participants, 150 were interventional (coronary) cardiologists (31.1%). Others were general cardiologists (n = 229), specialists in the field of rhythmology (n = 43), heart failure (n = 17) or imaging (n = 44). The survey consisted of 10 questions pertaining to 2 virtual clinical scenarios.Conclusions: The present survey is an illustration of how therapeutic decisions may vary in such situations with little or no scientific evidence. Such surveys may help experts to build consensus (answers with little variability) and to target the need for future trials and more research (answers with a lot of variability).Lire moins >
Lire la suite >Background: If several randomized studies allowed to better apprehend what should be the best antithrombotic strategy in patients with concomitant coronary artery disease (CAD) and atrial fibrillation (AF), there are still several clinical situations with a gap of evidence.Methods: We conducted a national French survey in September-October 2020 among cardiologists in order to assess what are daily practices regarding the antithrombotic management in several specific clinical settings where no or little scientific evidence is available. The questionnaires were built by a committee of 6 cardiologists routinely involved in the field of CAD and/or AF.Results: Among the 6388 French cardiologists, 483 (7.6%) cardiologists participated to the survey. The rate of participation was rather homogeneous across the country. The mean age of participants was 48 +/- 12.7. There were 134 women (27.7%) and 349 men. Altogether, 181 (37.5%) cardiologists worked in private, 153 (31.7%) in non-universitary public and 83 (17.2%) in universitary public centers. The remaining had shared activity. Among the participants, 150 were interventional (coronary) cardiologists (31.1%). Others were general cardiologists (n = 229), specialists in the field of rhythmology (n = 43), heart failure (n = 17) or imaging (n = 44). The survey consisted of 10 questions pertaining to 2 virtual clinical scenarios.Conclusions: The present survey is an illustration of how therapeutic decisions may vary in such situations with little or no scientific evidence. Such surveys may help experts to build consensus (answers with little variability) and to target the need for future trials and more research (answers with a lot of variability).Lire moins >
Langue :
Anglais
Comité de lecture :
Oui
Audience :
Internationale
Vulgarisation :
Non
Collections :
Source :
Fichiers
- document
- Accès libre
- Accéder au document
- S0167527321019665.pdf
- Accès libre
- Accéder au document